pharmaphorum

NOVEMBER 2, 2020

The UK drugs regulator has awarded a £1.5 million tender to a software company for an artificial intelligence tool that will be used to process “the expected high volume of COVID-19 vaccine adverse drug reactions (ADRs).”. The tender awarded to Maidenhead, Berkshire-based GenPact UK aims to “ensure that no details from the ADRs…are missed” as the UK prepares to start rolling out COVID-19 vaccines – assuming their safety and efficacy is supported in late-stage trials.

Vaccines 145

Vaccines 145

Outsourcing Pharma

NOVEMBER 4, 2020

The agency has chosen Continuity Pharma to aid in development and advancement of continuous manufacturing technology, with the help of a $1.5m grant.

102

102

Druggist

NOVEMBER 6, 2020

Chesty cough, also known as a productive cough, is characterised by overproduction of mucus. Chesty cough can commonly be a symptom of a common cold, but also other acute conditions such as bronchitis, or long term disease, for example, Chronic Obstructive Pulmonary Disease (COPD). Mucus accompanying a chesty cough can be clear or coloured (for example, yellow).

Immunization 69

Immunization 69

Pharma Times

NOVEMBER 2, 2020

It is hoped that findings from the NIHR-funded trial will help better inform treatment decisions

58

58

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

NOVEMBER 2, 2020

The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement the most cutting-edge technologies. At the heart of most of these digital advancements is AI and machine learning. With a collective sense of uncertainty, many are pinning their hopes on a vaccine and treatment, and sophisticated technology could help speed up the process of finding an effective medicine.

Vaccines 132

Vaccines Pharmaceutical Companies Pharmaceutical Companies Patient Care 132

Outsourcing Pharma

NOVEMBER 4, 2020

According to representatives from the pharma solutions provider, incorporation of CM processes, after a slow period, is expanding across the industry.

98

98

Pharma Times

NOVEMBER 3, 2020

Obesity management treatment recommended following confidential discount

58

58

pharmaphorum

NOVEMBER 3, 2020

Ring Chromosome 20 Syndrome, or (R)20, is an ultra-rare form of epilepsy with a devastating impact – yet despite huge leaps forward in gene sequencing in recent years, diagnoses are going down instead of up. We spoke to Allison Watson, co-founder of Ring 20 Research and Support, about raising awareness, building the evidence base, and the importance of helping people through a pandemic despite limited funding.

Hospitals 118

Hospitals 118

Outsourcing Pharma

NOVEMBER 2, 2020

Mission Bio has launched a tool it claims will help save the industry billions of dollars in drug development costs and bring life-saving treatments to market at least six months faster.

72

72

Pharma Mirror

NOVEMBER 4, 2020

To date, breast cancer is one of the most dangerous diseases. Unfortunately, it is not always possible to diagnose it early due to the lack of modern equipment in many countries. Medical tourism is getting popular, and you can easily get stage 4 breast cancer treatment in Germany. Modern hospitals in Germany have the most. The post Stage 4 Breast Cancer Treatment in Germany appeared first on Pharma Mirror Magazine.

Hospitals 52

Hospitals 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

NOVEMBER 4, 2020

British drugmaker confirmed review on Sunday

Vaccines 53

Vaccines 53

pharmaphorum

NOVEMBER 5, 2020

After three brushes with cancer, Robert Weker understands the patient journey more than many – and he is determined to put that experience to good use. The avid blogger and passionate advocate retired from his R&D role four years ago to focus on his own health, and now works full time on making sure the patient voice is “in the room” when pharma companies make decisions.

Chemotherapy 111

Chemotherapy Insurance Hospitals 111

Outsourcing Pharma

NOVEMBER 2, 2020

The latest analytical report from Life Science Strategy Group reveals position and perception of the leading players and performers in the eClinical arena.

64

64

Pharma Marketing Network

NOVEMBER 4, 2020

RJ (PMN): Hi this is RJ Lewis here for another episode of Pharma Marketing Networks Podcast. I have with me today Tom Ollerton from Automated Creative which is doing some really fascinating things when it comes to applying artificial intelligence to the creative development process in measuring process. Welcome Tom. Tom (AC): Thanks so much for having me RJ this is really brilliant to be invited on a podcast looking forward for a chat.

Compounding 52

Compounding 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Mirror

NOVEMBER 1, 2020

Accidents happen, people get sick, unexpected health issues pop up, problems occur when you least expect it – this is why there are emergency rooms and why millions of people go to them every year. Yet, visiting the emergency room can be very stressful and scary. You don’t know what is going to happen to. The post How Hospital Emergency Rooms are Improving Care appeared first on Pharma Mirror Magazine.

Hospitals 52

Hospitals 52

pharmaphorum

NOVEMBER 3, 2020

It could be possible to detect whether someone has COVID-19 or not, just from the sound of their coughing. That’s the conclusion of testing of an artificial intelligence (AI) algorithm developed by the Massachusetts Institute of Technology (MIT), which was able to detect around 98% of cases of COVID-19 from a forced cough delivered down a cell phone – confirmed by coronavirus testing.

Hospitals 110

Hospitals 110

Outsourcing Pharma

NOVEMBER 3, 2020

The Serialized Product Intelligence application uses serialization data to help operations streamline supply-chain operations, resolve issues and more.

52

52

Pharma Times

NOVEMBER 2, 2020

The move gives the French drug giant access to Kiadis' natural killer cell technology platform

51

51

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Marketing Network

NOVEMBER 6, 2020

The Pharma Marketing Wire is the bi-monthly e-newsletter of the Pharma Marketing Network® (PMN), which features original articles from pharmaceutical marketing experts and industry executives. These articles typically highlight facts and/or author opinions, market research data, and offer expertise within the pharmaceutical and healthcare landscapes.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

NOVEMBER 4, 2020

Professor Jean-Pierre Boissel outlines the urgent need for disruptive R&D approaches that can tackle the search for COVID-19 treatments more effectively. It may not be appropriate to use the word ‘failure’ when summarising the utility of clinical trials in the search for a curative or preventative treatment for disease. For the purposes of this text, let us assume that ‘success’ and ‘failure’ will be used in reference to the objective of clinical trial designers: to obtain sufficient evidenc

Vaccines 105

Vaccines Immunization FDA 105

Outsourcing Pharma

NOVEMBER 5, 2020

With the Open Wearables initiative, Shimmer Research is looking to bring research professionals together on solutions for the common good of the industry.

52

52

Pharma Times

NOVEMBER 5, 2020

SGLT2 inhibitor approved for heart failure with reduced ejection fraction

50

50

Med Ed 101

NOVEMBER 4, 2020

Hydralazine is a medication that causes vasodilation on the arterioles which ultimately leads to a reduction in blood pressure. It isn’t a medication that is used terribly often and I will discuss the reasons for this as well as other hydralazine clinical pearls you should be aware of. Hydralazine Clinical Pearls – Why Isn’t It […]. The post Hydralazine Clinical Pearls appeared first on Med Ed 101.

40

40

pharmaphorum

NOVEMBER 5, 2020

An experimental gene therapy developed by Texas biotech Genprex will be paired with AstraZeneca’s Tagrisso and Merck & Co’s Keytruda – both leading their respective drug classes in the treatment of non-small cell lung cancer (NSCLC). The two phase 1/2 trials are zeroing in on NSCLC patients with specific molecular biomarkers, to see if adding Genprex’ Reqorsa (quaratusugene ozeplasmid) – which delivers a gene that suppresses tumour growth – can enhance the activity of the AZ and Merck

FDA 98

FDA 98

Outsourcing Pharma

NOVEMBER 4, 2020

The two firms are joining forces to help life-sciences customers speed up adoption of continuous manufacturing in pharmaceutical processes.

52

52

Pharma Times

NOVEMBER 5, 2020

NHS Confederation chief exec calls on public to support non-COVID services

49

49

Med Ed 101

NOVEMBER 1, 2020

In this case scenario, we discuss the potential risk of leaving the nicotine patch on overnight. A 55-year-old female has a history of hypertension, GERD, and is currently a cigarette smoker. She has tried over 10 times in the last 15-20 years to quit smoking to no avail. She has tried varenicline, nicotine gum, and […]. The post Leaving The Nicotine Patch On Overnight appeared first on Med Ed 101.

40

40

pharmaphorum

NOVEMBER 2, 2020

It’s a safe bet that most people’s first introduction to CDISC standards is through the Study Data Tabulation Model (SDTM). This is a content standard that ensures clinical data is submitted in a consistent manner, helping to reduce review time and facilitating cross-study analysis. Another content standard, the Analysis Data Model (ADaM), aims to perform a similar function for analysis datasets.

FDA 98

FDA 98

Outsourcing Pharma

NOVEMBER 4, 2020

Leaders from the CDMO discuss how the surging interest in continuous manufacturing can result in cost savings and numerous other advantages.

52

52

Pharma Times

NOVEMBER 2, 2020

Zejula is the first PARP inhibitor to be approved as monotherapy in the EU for patients with platinum-responsive advanced ovarian cancer, regardless of biomarker status

43

43

pharmaphorum

NOVEMBER 2, 2020

Sanofi is to acquire Kiadis, a biotech specialising in therapies based around ‘off the shelf’ natural killer (NK) cells, for 308 million euros ($353 million). The French pharma is buying Kiadis for 5.45 euros per share in cash, an offer price representing a premium of 272% over the biotech’s closing price on Friday evening on Amsterdam’s Euronext market.

98

98

pharmaphorum

NOVEMBER 4, 2020

Novartis’ injectable migraine prevention antibody Aimovig has been shown to be more effective than topiramate – a go-to oral therapy for people with chronic migraine – in a head-to-head trial. The HER-MES trial found that Aimovig (erenumab) was more effective at preventing migraine attacks and also better tolerated than topiramate, a generic epilepsy drug which is known to have side effects like sleepiness, dizziness, diarrhoea and nausea.

96

96

pharmaphorum

NOVEMBER 4, 2020

Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The latest cash injection adds to the €118 million initially raised by Fountain Healthcare for the fund in May 2019, and brings the total value managed by the company above the €300 million mark.

FDA 96

FDA 96